Rare infantile hemangioma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:210589
Who is this for?
Show terms as
3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare infantile hemangioma refers to uncommon variants or presentations of infantile hemangiomas (IH) — benign vascular tumors composed of proliferating endothelial cells that typically appear shortly after birth. While common infantile hemangiomas affect approximately 4-5% of infants, the designation 'rare infantile hemangioma' under Orphanet (ORPHA:210589) encompasses atypical forms that may include unusual locations, morphologies, or complications that distinguish them from typical superficial or uncomplicated hemangiomas. These rare presentations may involve deep or visceral structures, segmental distributions, or multifocal disease. Infantile hemangiomas characteristically undergo a proliferative phase during the first weeks to months of life, followed by a slow involution phase that can last several years. Rare forms may affect the skin, subcutaneous tissues, liver, airway, gastrointestinal tract, or other internal organs. Key clinical features can include a rapidly growing vascular mass, ulceration, bleeding, functional impairment (such as visual obstruction when periorbital, or airway compromise in subglottic locations), and in cases of large or hepatic hemangiomas, high-output cardiac failure or consumptive hypothyroidism. Segmental hemangiomas may be associated with PHACE syndrome (posterior fossa anomalies, hemangioma, arterial anomalies, cardiac defects, and eye abnormalities) or LUMBAR syndrome. Treatment depends on the location, size, and associated complications. Oral propranolol is the first-line systemic therapy and has revolutionized management since its introduction, significantly reducing the need for surgical intervention. Topical timolol may be used for smaller, superficial lesions. In refractory or life-threatening cases, systemic corticosteroids, vincristine, or surgical excision may be considered. Laser therapy can address residual telangiectasias. Close monitoring by a multidisciplinary team including dermatology, pediatric surgery, and relevant subspecialists is recommended for rare or complicated presentations.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rare infantile hemangioma.

View clinical trials →

No actively recruiting trials found for Rare infantile hemangioma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare infantile hemangioma community →

Specialists

3 foundView all specialists →
CD
Camila MV Moniz, Doctor
SAN ANTONIO, TX
Specialist
PI on 1 active trial
MW
Michael Weller
Specialist
PI on 2 active trials1 Rare infantile hemangioma publication
LS
Lois Hodgson Smith
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare infantile hemangioma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare infantile hemangiomaForum →

No community posts yet. Be the first to share your experience with Rare infantile hemangioma.

Start the conversation →

Latest news about Rare infantile hemangioma

No recent news articles for Rare infantile hemangioma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Rare infantile hemangioma

What is Rare infantile hemangioma?

Rare infantile hemangioma refers to uncommon variants or presentations of infantile hemangiomas (IH) — benign vascular tumors composed of proliferating endothelial cells that typically appear shortly after birth. While common infantile hemangiomas affect approximately 4-5% of infants, the designation 'rare infantile hemangioma' under Orphanet (ORPHA:210589) encompasses atypical forms that may include unusual locations, morphologies, or complications that distinguish them from typical superficial or uncomplicated hemangiomas. These rare presentations may involve deep or visceral structures, seg

How is Rare infantile hemangioma inherited?

Rare infantile hemangioma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Rare infantile hemangioma typically begin?

Typical onset of Rare infantile hemangioma is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Rare infantile hemangioma?

3 specialists and care centers treating Rare infantile hemangioma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.